Mitochondrial activity contributes to impaired renal metabolic homeostasis and renal pathology in STZ-induced diabetic mice
- 1 September 2019
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 317 (3) , F593-F605
Abstract
Diabetic nephropathy (DN) has become the main cause of end-stage renal disease worldwide while the efficacy of current therapeutic strategies on DN remains unsatisfactory. Recent researches reported the involvement of metabolic re-arrangement in the pathological process of DN, and of all the disturbances in metabolism, mitochondria serve as key regulatory hubs. In the present study, high-resolution mass spectrometry-based none-target metabolomics was employed to uncover the metabolic characteristics of early diabetic kidney with or without the inhibition of mitochondrial activity. At first, we observed a moderate enhancement of mitochondrial complex-1 activity in diabetic kidney, which was completely normalized by a specific mitochondrial complex-1 inhibitor rotenone (ROT). Meanwhile, metabolomics data indicated over-activated pentose phosphate pathway, purine and pyrimidine metabolism, hexosamine biosynthetic pathway, and Kreb cycle, which were strikingly corrected by ROT. In addition, ROT also strikingly corrected imbalanced redox homeostasis possibly by increasing the ratio of antioxidant metabolites GSH and NAPDH against their oxidative form. In agreement with the improved metabolic status and oxidative response, ROT attenuated glomerular and tubular injury efficiently. The fibrotic markers (fibronectin, α-SMA, collagen I and collagen III), inflammatory factors (TNF-ᵯC;, IL-1ᵯD;, and ICAM-1) and oxidative stress were all markedly blocked by ROT. In vitro, ROT dose-dependently attenuated high glucose-induced proliferation and extracellular matrix production in mesangial cells. Collectively, these findings revealed that the overactivation of mitochondrial activity in kidney could contribute to the metabolic disorders and the pathogenesis of early diabetic nephropathy.Keywords
This publication has 48 references indexed in Scilit:
- GC/TOFMS analysis of metabolites in serum and urine reveals metabolic perturbation of TCA cycle in db/db mice involved in diabetic nephropathyAmerican Journal of Physiology-Renal Physiology, 2013
- Activation of peroxisome proliferator-activated receptor-γ coactivator 1α ameliorates mitochondrial dysfunction and protects podocytes from aldosterone-induced injuryKidney International, 2012
- A positive/negative ion–switching, targeted mass spectrometry–based metabolomics platform for bodily fluids, cells, and fresh and fixed tissueNature Protocols, 2012
- The targeted podocyteJournal of Clinical Investigation, 2011
- Mitochondrial control of the NLRP3 inflammasomeNature Immunology, 2011
- Disparate effects on renal and oxidative parameters following RAGE deletion, AGE accumulation inhibition, or dietary AGE control in experimental diabetic nephropathyAmerican Journal of Physiology-Renal Physiology, 2010
- RAGE-Induced Cytosolic ROS Promote Mitochondrial Superoxide Generation in DiabetesJournal of the American Society of Nephrology, 2009
- Rodent models of streptozotocin‐induced diabetic nephropathy (Methods in Renal Research)Nephrology, 2007
- Aldose reductase and the role of the polyol pathway in diabetic nephropathyKidney International, 2000
- Role of the hexosamine biosynthetic pathway in diabetic nephropathyKidney International, 2000